Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_assertion description "[Small molecule inhibitors targeting the kinase activity of ALK have proven to be effective therapies in certain ALK-driven malignancies and one such inhibitor, crizotinib, is now approved for the treatment of EML4-ALK-driven, non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_assertion evidence source_evidence_literature NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_assertion SIO_000772 22932897 NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_assertion wasDerivedFrom befree-20150227 NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_assertion wasGeneratedBy ECO_0000203 NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP890464.RAZBZEd4K27ISVrgOupEZjfQ4wGmHgPAlW2ROMPU8cwrE130_provenance.